Nanotechnology approaches for antibacterial drug delivery: Preparation and microbiological evaluation of fusogenic liposomes carrying fusidic acid

International Journal of Antimicrobial Agents

Volumn 45, Issue 6, 2015, Pages 622-626

  Nicolosi, Daria ^a   Cupri, Sarha ^a   Genovese, Carlo ^a   Tempera, Gianna ^a   Mattina, Roberto ^b   Pignatello, Rosario ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Acinetobacter baumannii; Fusogenic liposomes; Gram negative bacteria; Gram positive bacteria; SUVET

Indexed keywords

ANTIINFECTIVE AGENT; FUSIDIC ACID; LIPOSOME;

DRUG DELIVERY SYSTEM; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; METABOLISM; NANOTECHNOLOGY; PROCEDURES;

ANTI-BACTERIAL AGENTS; DRUG DELIVERY SYSTEMS; FUSIDIC ACID; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; LIPOSOMES; NANOTECHNOLOGY;

EID: 84939979098     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.01.016     Document Type: Article

References (30)

1. H. Nikaido Prevention of drug access to bacterial targets: permeability barriers and active efflux Science 264 1994 382 388
2. H. Pinto-Alphandary, A. Andremont, and P. Couvreur Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications Int J Antimicrob Agents 13 2000 155 168
3. A. Samad, Y. Sultana, and M. Aqil Liposomal drug delivery systems: an update review Curr Drug Deliv 4 2007 297 305
4. M. Alhariri, A. Azghani, and A. Omri Liposomal antibiotics for the treatment of infectious diseases Expert Opin Drug Deliv 10 2013 1515 1532
5. J.P. Motion, J. Nguyen, and F.C. Szoka Phosphatase-triggered fusogenic liposomes for cytoplasmic delivery of cell-impermeable compounds Angew Chem Int Ed Engl 51 2012 9047 9051
6. J. Kunisawa, T. Masuda, K. Katayama, T. Yoshikawa, Y. Tsutsumi, M. Akashi, et al. Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release J Control Release 105 2005 344 353
7. M. Vidal, and D. Hoekstra In vitro fusion of reticulocyte endocytic vesicles with liposomes J Biol Chem 270 1995 17823 17829
8. J.A. Boomer, M.M. Qualls, H.D. Inerowicz, R.H. Haynes, V.S. Patri, J.M. Kim, et al. Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate Bioconjug Chem 20 2009 47 59
9. M. Vidal, and D. Hoekstra In vitro fusion of reticulocytes endocytic vesicles with liposomes J Biol Chem 270 1995 17823 17829
10. D. Nicolosi, M. Scalia, V.M. Nicolosi, and R. Pignatello Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria Int J Antimicrob Agents 35 2010 553 558
11. R. Pignatello, M.G. Sarpietro, V.M. Nicolosi, and D. Nicolosi Effect of composition on the in vitro activity of fusogenic liposomes loaded with vancomycin against Gram-negative bacteria Inventi Impact - NDDS 2 2011 92 94
12. D. Nicolosi, V.M. Nicolosi, and R. Pignatello Fusogenic liposomes as a new carrier to enlarge the spectrum of action of antibiotics against Gram-negative bacteria In: A. Mendez-Vilas, editor. Science against microbial pathogens: communicating current research and technological advances. Microbiology Book Series No. 3 2011 Formatex Badajoz, Spain 52 60
13. T.J. Silhavy, D. Kahne, and S. Walker The bacterial cell envelope Cold Spring Harb Perspect Biol 2 2010 a000414
14. P. Collignon, and J. Turnidge Fusidic acid in vitro activity Int J Antimicrob Agents 12 Suppl 2 1999 S45 S58
15. L. Verbist The antimicrobial activity of fusidic acid J Antimicrob Chemother 25 Suppl B 1990 1 5
16. J. Turnidge, and P. Collignon Resistance to fusidic acid Int J Antimicrob Agents 12 Suppl 2 1999 S35 S44
17. D.J. Farrell, M. Castanheira, and I. Chopra Characterization of global patterns and the genetics of fusidic acid resistance Clin Infect Dis 52 Suppl 7 2011 S487 S492
18. I. Chopra Mechanisms of resistance to fusidic acid in Staphylococcus aureus J Gen Microbiol 96 1976 229 238
19. A.L. Smith, and J.L. Burns Resistance to chloramphenicol and fusidic acid In: L. Bryan, editor Antimicrobial drug resistance 1984 Elsevier 293 315
20. E. Falck, J.T. Hautala, M. Karttunen, P.K.J. Kinnunen, M. Patra, H. Saaren-Seppala, et al. Interaction of fusidic acid with lipid membranes: implications to the mechanism of antibiotic activity Biophys J 91 2006 1787 1799
21. A. Helle, J. Makiyalo, J. Huhtanen, J.M. Holopainen, and S.K. Wiedmer Antibiotic fusidic acid has strong interactions with negatively charged lipid membranes: an electrokinetic capillary chromatographic study Biochim Biophys Acta 1778 2008 1640 1647
22. J. Lasch, V. Weissig, and M. Brandl Preparation of liposomes In: V.P. Torchilin, V. Weissig, editors Liposomes: a practical approach 2nd ed. 2003 Oxford University Press Oxford, UK 3 30
23. A.H. Hikal, A. Shibl, and S. El-Hoofy Determination of sodium fusidate and fusidic acid in dosage forms by high-performance liquid chromatography and a microbiological method J Pharm Sci 71 1982 1297 1298
24. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. Document M100-S23 2013 CLSI Wayne, PA
25. B. Mui, L. Chow, and M.J. Hope Extrusion technique to generate liposomes of defined size Methods Enzymol 367 2003 3 14
26. N-J. Cho, L.Y. Hwang, J.J.R. Solandt, and C.W. Frank Comparison of extruded and sonicated vesicles for planar bilayer self-assembly Materials 6 2013 3294 3308
27. P.M. Furneri, M. Fresta, G. Puglisi, and G. Tempera Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria Antimicrob Agents Chemother 44 2000 2458 2464
28. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0 2014 http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/Breakpoint-table-v-4.0.pdf [accessed May 2014]
29. D.M. Guerrero, F. Perez, N.G. Conger, J.S. Solomkin, M.D. Adams, P.N. Rather, et al. Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease Surg Infect (Larchmt) 11 2010 49 57
30. Y. Hiraki, M. Yoshida, Y. Masuda, D. Inoue, Y. Tsuji, H. Kamimura, et al. Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy Int J Infect Dis 17 2013 e1234 e1236